Sino Biological, Inc., currently listed on the Shenzhen stock exchange subsidiary ChiNext, is an international reagent supplier and premium technical contract service, provider. Since 2007, we have committed to providing high-quality, independently developed, and produced recombinant proteins, antibodies, and cDNA clones for basic, translational, and clinical research.
